The efficacy and safety of keverprazan-amoxicillin dual therapy in the treatment of Helicobacter pylori: A multicenter, open-label, non-inferiority randomized controlled trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: f58196c436d980fa0c81050d61bee59b90eeb087
First added on: Sep 06, 2025